Montelukast Prescribing at STANLEY MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,030
Total Quantity
41.6K
NHS Cost
£2.1K
vs National Avg
+196.5%
STANLEY MEDICAL GROUP prescribed 2,030 items of Montelukast over the last 12 months at a cost of £2,116 to the NHS. This is 196.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
188
Jul 2026
158
Jul 2026
193
Jul 2026
165
Jul 2026
155
Jul 2026
168
Jul 2026
169
Jul 2026
153
Jul 2026
181
Jul 2026
168
Jul 2026
170
Jul 2026
162
Prescribing Details
| Total Items | 2,030 |
|---|---|
| Total Quantity | 41,622 |
| Total NHS Cost | £2,116 |
| Presentations | 4 different forms |
| vs National Average | +196.5% |
Montelukast Prescribing Comparison
| This practice | 2,030 items |
|---|---|
| National average per practice | 685 items |
| Difference | +196.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.